Skin & Coat: Scientific Research & Clinical Trials

Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK.

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.

Epigenetic control of skin differentiation genes by phytocannabinoids.

A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ.

Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation

Attenuation of allergic contact dermatitis through the endocannabinoid system.

Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus

The role of cannabinoids in dermatology.